Functional evaluation of conventional 'Celsite®' venous ports versus 'Vortex®' ports with a tangential outlet: A prospective randomised pilot study

Supportive Care in Cancer

Volumn 16, Issue 12, 2008, Pages 1367-1374

  Goossens, G A ^a,b   Verbeeck, G ^b   Moons, P ^b   Sermeus, W ^b   De Wever, I ^a   Stas, M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Catheterization, Central Venous; Implantable catheter; Vacutainer ; Vascular access ports; Withdrawal occlusion

Indexed keywords

ADULT; AGED; ARTICLE; CATHETER OCCLUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOLID TUMOR; VASCULAR ACCESS; VASCULAR ACCESS DEVICE; VEIN CATHETERIZATION;

ADULT; AGED; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS; PHLEBOTOMY; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 55549090354     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-008-0436-y     Document Type: Article

References (26)

1. R Biffi BF De F Orsi S Pozzi P Arnaldi A Goldhirsch N Rotmensz C Robertson M Bellomi B Andreoni 2001 A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients Cancer 92 1204 1212
2. J Caers C Fontaine V Vinh-Hung J De Mey G Ponnet C Oost J Lamote J De Greve B Van Camp P Lacor 2005 Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports Support Care Cancer 13 325 331
3. JT Carlo JP Lamont TM McCarty S Livingston JA Kuhn 2004 A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports Am J Surg 188 722 727
4. DE Cohn DG Mutch JS Rader M Farrell R Awantang TJ Herzog 2001 Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies Gynecol Oncol 83 533 536
5. GA Goossens M Vrebos I De Wever M Stas 2004 Vacutainer filling time through subcutaneous venous access devices J Vasc Access 5 154 160
6. L Goossens M Jérôme M Stas 2005 Verstopte poortkatheters: hoe vaak komt dit voor en wat doen verpleegkundigen hieraan? Oncologisch Tijdschrift 23 28 29
7. L Goossens M Vrebos M Stas L Rottiers G Evers 2004 De incidentie van verstopping, trombose, infectie en extravasatie bij subcutaan veneuze poortkatheters van oncologische patiënten in Vlaamse ziekenhuizen. Een eerste analyse Oncologisch Tijdschrift 21 54 59
8. SM Hou PC Wang YC Sung HH Lee HT Liu YH Chen 2005 Comparisons of outcomes and survivals for two central venous access port systems J Surg Oncol 91 61 66
9. F Krug D Psathakis U Hirsch H Bruch 1999 The K-port concept: proposal for optimising a fully implantable port system J Oncol Pharm Practice 5 67 74
10. F Lakdja N Roubault JM Fonrouge 1999 [A new system for permanent venous access, Cathlink 20: prospective clinical study. 95 cases] Pathol Biol (Paris) 47 273 278
11. JP Lamont TM McCarty JS Stephens BA Smith J Carlo S Livingston JA Kuhn 2003 A randomized trial of valved vs nonvalved implantable ports for vascular access Proc Bayl Univ Med Cent 16 384 387
12. G Lundberg E Wahlberg A Rickberg P Olofsson 1995 PAS-Port: a new implantable vascular access device for arm placement: experiences from the first two years Eur J Surg 161 323 326
13. VA Minassian AK Sood P Lowe JI Sorosky AS Al-Jurf RE Buller 2000 Longterm central venous access in gynecologic cancer patients J Am Coll Surg 191 403 409
14. S Moll P Kenyon L Bertoli MJ De H Homesley SR Deitcher 2006 Phase II trial of alfimeprase, a novel-acting fibrin degradation agent, for occluded central venous access devices J Clin Oncol 24 3056 3060
15. JE Niederhuber W Ensminger JW Gyves M Liepman K Doan E Cozzi 1982 Totally implanted venous and arterial access system to replace external catheters in cancer treatment Surgery 92 706 712
16. J Petersen JH Delaney MT Brakstad RK Rowbotham CM Bagley Jr. 1999 Silicone venous access devices positioned with their tips high in the superior vena cava are more likely to malfunction Am J Surg 178 38 41
17. D Ponec D Irwin WD Haire PA Hill X Li ER McCluskey 2001 Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial-the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial J Vasc Interv Radiol 12 951 955
18. OW Press PG Ramsey EB Larson A Fefer RO Hickman 1984 Hickman catheter infections in patients with malignancies Medicine (Baltimore) 63 189 200
19. II Raad M Luna SA Khalil JW Costerton C Lam GP Bodey 1994 The relationship between the thrombotic and infectious complications of central venous catheters JAMA 271 1014 1016
20. JC Schutz AA Patel TW Clark JA Solomon DB Freiman CM Tuite JI Mondschein MC Soulen RD Shlansky-Goldberg SW Stavropoulos A Kwak JL Chittams SO Trerotola 2004 Relationship between chest port catheter tip position and port malfunction after interventional radiologic placement J Vasc Interv Radiol 15 581 587
21. CP Semba SR Deitcher X Li L Resnansky T Tu ER McCluskey 2002 Treatment of occluded central venous catheters with alteplase: results in 1,064 patients J Vasc Interv Radiol 13 1199 1205
22. M Stas S Mulier P Pattyn J Vijgen I De Wever 2001 Peroperative intravasal electrographic control of catheter tip position in access ports placed by venous cut-down technique Eur J Surg Oncol 27 316 320
23. B Stevens SE Barton M Brechbill S Moenter AL Piel D Shankle 2000 A randomized, prospective trial of conventional vascular ports vs. the vortex "clear-flow" reservoir port in adult oncology patients J Vasc Access Devices 5 4 37 40
24. P Svoboda RP Barton OL Barbarash AA Butylin BR Jacobs J Lata WD Haire MR Jaff CM Firszt TL Mouginis DM Schuerr GA Schulz LB Schwartz MA El-Shahawy 2004 Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial Crit Care Med 32 1990 1996
25. P Verhamme G Goossens G Maleux D Collen M Stas 2007 A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion J Thromb Thrombolysis 24 1 5
26. TM Vesely 2003 Central venous catheter tip position: a continuing controversy J Vasc Interv Radiol 14 527 534